- Home
- FMS vs ICLR Comparison
FMS vs ICLR Comparison
Compare FMS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- ICLR
- Stock Information
- Founded
- FMS 1996
- ICLR 1990
- Country
- FMS Germany
- ICLR Ireland
- Employees
- FMS N/A
- ICLR N/A
- Industry
- FMS Misc Health and Biotechnology Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FMS Health Care
- ICLR Health Care
- Exchange
- FMS Nasdaq
- ICLR Nasdaq
- Market Cap
- FMS 14.1B
- ICLR 14.3B
- IPO Year
- FMS 1996
- ICLR 1998
- Fundamental
- Price
- FMS $23.99
- ICLR $157.88
- Analyst Decision
- FMS Sell
- ICLR Buy
- Analyst Count
- FMS 2
- ICLR 15
- Target Price
- FMS $30.00
- ICLR $211.36
- AVG Volume (30 Days)
- FMS 440.0K
- ICLR 996.7K
- Earning Date
- FMS 11-04-2025
- ICLR 10-22-2025
- Dividend Yield
- FMS 2.38%
- ICLR N/A
- EPS Growth
- FMS 8.40
- ICLR N/A
- EPS
- FMS 2.86
- ICLR 7.47
- Revenue
- FMS $23,046,819,198.00
- ICLR $8,102,602,000.00
- Revenue This Year
- FMS $1.75
- ICLR N/A
- Revenue Next Year
- FMS $3.01
- ICLR $0.89
- P/E Ratio
- FMS $16.47
- ICLR $21.29
- Revenue Growth
- FMS 2.10
- ICLR N/A
- 52 Week Low
- FMS $21.06
- ICLR $125.10
- 52 Week High
- FMS $30.46
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- FMS 27.16
- ICLR 33.43
- Support Level
- FMS $23.50
- ICLR $159.19
- Resistance Level
- FMS $24.63
- ICLR $167.87
- Average True Range (ATR)
- FMS 0.40
- ICLR 8.45
- MACD
- FMS -0.41
- ICLR -2.75
- Stochastic Oscillator
- FMS 12.31
- ICLR 4.93
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.